Medication adherence and its associated factors among diabetic patients at Zewditu Memorial Hospital, Addis Ababa, Ethiopia

Muhammed Ali, Tigestu Alemu, Oumer Sada, Muhammed Ali, Tigestu Alemu, Oumer Sada

Abstract

Objective: Diabetes is a global problem with devastating human, social and economic impact. Anti-diabetic medications play a major role in the glycemic control of patients with diabetes. However, inadequate adherence compromises safety and treatment effectiveness, leading to increased mortality and morbidity. The aim of this study was to assess adherence to anti-diabetic medications and associated factors among patient with diabetes mellitus receiving care at Zewditu Memorial Hospital.

Results: Among the total of 146 diabetic patients (mean age 46.5 ± 14.7), the level of adherence to anti diabetic medication was 54.8% (80) whilst 45.2% (66) of the participants were non adherent. Multiple logistic regression showed that knowledge of medication (AOR = 4.905, 95% CI 1.64-14.62, medication availability (AOR = 0.175, 95% CI 0.031-0.987) and education level (AOR = 13.65, 95% CI 1.45-128.456) were reasons for non-adherence.

Keywords: Addis Ababa; Adherence; Anti diabetic medication; Diabetes; Zewditu Memorial Hospital.

Figures

Fig. 1
Fig. 1
Distribution of participants on knowledge of diabetics and medication

References

    1. American Diabetes Association Diagnosis and classification of diabetes mellitus. Diabetes Care. 2004;27:5–10. doi: 10.2337/diacare.27.2007.S5.
    1. Kaufman FR, editor. Medical management of type 1 diabetes. 6th ed. Alexandria: American Diabetes Association; 2012.
    1. Dipiro JT, Talbert RL, Yee GC, Matzke GR, Wells BG, Posey LM. Pharmacotherapy—a pathophysiologic approach, 9th edn. USA: McGraw-Hill Professional; 2014
    1. World Health Organization . Global report on diabetes. Geneva: World Health Organization; 2016.
    1. International Diabetes Federation . Diabetes atlas. 2. Brussels: International Diabetes Federation; 2003.
    1. International Diabetes Federation . IDF diabetes atlas. 7. Brussels: International Diabetes Federation; 2015.
    1. Sicree R, Shaw J. Zimmet: the global burden: diabetes and impaired glucose tolerance. Brussels: Diabetes Atlas, IDF; 2009.
    1. World Health Organization . Global health risks. Mortality and burden of disease attributable to selected major risks. Geneva: World Health Organization; 2009.
    1. World Health Organization (WHO) Adherence to long-term therapies: evidence for action. Geneva: WHO; 2003.
    1. Cramer JA. A systematic review of adherence with medications for diabetes. Diabetes Care. 2004;27(5):1218–1224. doi: 10.2337/diacare.27.5.1218.
    1. Gelaw BK, Mohammed A, Tegegne GT, Defersha AD, Fromsa M, Tadesse E, et al. Nonadherence and contributing factors among ambulatory patients with antidiabetic medications in Adama Referral Hospital. J Diabetes Res. 2014;2014:617041. doi: 10.1155/2014/617041.
    1. Mohammed AR, Lisha JS, Jayakumary J, et al. Patients adherence to anti-diabetic medications in a hospital at Ajman, UAE. Malays J Med Sci. 2014;21(1):44–49.
    1. Bagonza J, Rutebemberwa E, Bazeyo W. Adherence to anti diabetic medication among patients with diabetes in eastern Uganda, 2015, a cross sectional study. BMC Health Serv Res. 2015;15:168. doi: 10.1186/s12913-015-0820-5.
    1. Teklay G, Hussien J, Tesfaye D. Non-adherence and associated factors among type 2 diabetic patients at Jimma University Specialized Hospital, Southwest Ethiopia. J Med Sci. 2013;13:578–584. doi: 10.3923/jms.2013.578.584.
    1. Cooper C, Carpenter I, Katona C, et al. The AdHOC study of older adults’ adherence to medication in 11 countries. Am J Geriatr Psychiatry. 2005;13:1067–1076. doi: 10.1097/00019442-200512000-00006.
    1. Jackson IL, Adibe MO, Okonta MJ, Ukwe CV. Medication adherence in type 2 diabetes patients in Nigeria. Diabetes Technol Therap. 2015;17(6):398–404. doi: 10.1089/dia.2014.0279.

Source: PubMed

Sponsorer och medarbetare

Medicinska tillstånd

Läkemedelsinterventioner

3
Prenumerera